388 related articles for article (PubMed ID: 35694541)
41. High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.
Grosheva I; Zheng D; Levy M; Polansky O; Lichtenstein A; Golani O; Dori-Bachash M; Moresi C; Shapiro H; Del Mare-Roumani S; Valdes-Mas R; He Y; Karbi H; Chen M; Harmelin A; Straussman R; Yissachar N; Elinav E; Geiger B
Gastroenterology; 2020 Nov; 159(5):1807-1823. PubMed ID: 32653496
[TBL] [Abstract][Full Text] [Related]
42. Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental Colitis.
Nighot M; Liao PL; Morris N; McCarthy D; Dharmaprakash V; Ullah Khan I; Dalessio S; Saha K; Ganapathy AS; Wang A; Ding W; Yochum G; Koltun W; Nighot P; Ma T
J Crohns Colitis; 2023 Apr; 17(4):565-579. PubMed ID: 36322638
[TBL] [Abstract][Full Text] [Related]
43. Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-κB activation.
Al-Sadi R; Engers J; Haque M; King S; Al-Omari D; Ma TY
PLoS One; 2021; 16(4):e0249544. PubMed ID: 33826658
[TBL] [Abstract][Full Text] [Related]
44. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.
Wilcz-Villega EM; McClean S; O'Sullivan MA
Am J Gastroenterol; 2013 Jul; 108(7):1140-51. PubMed ID: 23588236
[TBL] [Abstract][Full Text] [Related]
45. Kiwifruit cysteine protease actinidin compromises the intestinal barrier by disrupting tight junctions.
Grozdanovic MM; Čavić M; Nešić A; Andjelković U; Akbari P; Smit JJ; Gavrović-Jankulović M
Biochim Biophys Acta; 2016 Mar; 1860(3):516-26. PubMed ID: 26701113
[TBL] [Abstract][Full Text] [Related]
46. Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins.
Kumar A; Chatterjee I; Anbazhagan AN; Jayawardena D; Priyamvada S; Alrefai WA; Sun J; Borthakur A; Dudeja PK
Cell Microbiol; 2018 Jun; 20(6):e12830. PubMed ID: 29444370
[TBL] [Abstract][Full Text] [Related]
47. The In Vitro Protective Role of Bovine Lactoferrin on Intestinal Epithelial Barrier.
Zhao X; Xu XX; Liu Y; Xi EZ; An JJ; Tabys D; Liu N
Molecules; 2019 Jan; 24(1):. PubMed ID: 30609730
[TBL] [Abstract][Full Text] [Related]
48. Barrier Protection and Recovery Effects of Gut Commensal Bacteria on Differentiated Intestinal Epithelial Cells In Vitro.
Mohebali N; Ekat K; Kreikemeyer B; Breitrück A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32731411
[TBL] [Abstract][Full Text] [Related]
49. IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
Rawat M; Nighot M; Al-Sadi R; Gupta Y; Viszwapriya D; Yochum G; Koltun W; Ma TY
Gastroenterology; 2020 Oct; 159(4):1375-1389. PubMed ID: 32569770
[TBL] [Abstract][Full Text] [Related]
50. Methotrexate modulates tight junctions through NF-κB, MEK, and JNK pathways.
Beutheu Youmba S; Belmonte L; Galas L; Boukhettala N; Bôle-Feysot C; Déchelotte P; Coëffier M
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):463-70. PubMed ID: 22197938
[TBL] [Abstract][Full Text] [Related]
51. Intestinal alkaline phosphatase inhibits the translocation of bacteria of gut-origin in mice with peritonitis: mechanism of action.
Wang W; Chen SW; Zhu J; Zuo S; Ma YY; Chen ZY; Zhang JL; Chen GW; Liu YC; Wang PY
PLoS One; 2015; 10(5):e0124835. PubMed ID: 25946026
[TBL] [Abstract][Full Text] [Related]
52.
Hung YK; Ho ST; Kuo CY; Chen MJ
Int J Med Sci; 2021; 18(8):1778-1785. PubMed ID: 33746595
[No Abstract] [Full Text] [Related]
53. Resveratrol attenuates intestinal epithelial barrier dysfunction via Nrf2/HO-1 pathway in dextran sulfate sodium-induced Caco-2 cells.
Yu X; Wang Y; Xu Y; Li X; Zhang J; Su Y; Guo L
Immun Inflamm Dis; 2024 Feb; 12(2):e1193. PubMed ID: 38372468
[TBL] [Abstract][Full Text] [Related]
54. Flavonoids modulate tight junction barrier functions in hyperglycemic human intestinal Caco-2 cells.
Sharma S; Tripathi P; Sharma J; Dixit A
Nutrition; 2020 Oct; 78():110792. PubMed ID: 32473529
[TBL] [Abstract][Full Text] [Related]
55. The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured.
Palumbo P; Lombardi F; Cifone MG; Cinque B
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):199-206. PubMed ID: 30360752
[TBL] [Abstract][Full Text] [Related]
56. Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy.
Feng Y; Wang Y; Wang P; Huang Y; Wang F
Cell Physiol Biochem; 2018; 49(1):190-205. PubMed ID: 30138914
[TBL] [Abstract][Full Text] [Related]
57. Salmosan, a β-Galactomannan-Rich Product, Protects Epithelial Barrier Function in Caco-2 Cells Infected by Salmonella enterica Serovar Enteritidis.
Brufau MT; Campo-Sabariz J; Bou R; Carné S; Brufau J; Vilà B; Marqués AM; Guardiola F; Ferrer R; Martín-Venegas R
J Nutr; 2016 Aug; 146(8):1492-8. PubMed ID: 27358412
[TBL] [Abstract][Full Text] [Related]
58. IL-1beta causes an increase in intestinal epithelial tight junction permeability.
Al-Sadi RM; Ma TY
J Immunol; 2007 Apr; 178(7):4641-9. PubMed ID: 17372023
[TBL] [Abstract][Full Text] [Related]
59. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
Marchelletta RR; Krishnan M; Spalinger MR; Placone TW; Alvarez R; Sayoc-Becerra A; Canale V; Shawki A; Park YS; Bernts LH; Myers S; Tremblay ML; Barrett KE; Krystofiak E; Kachar B; McGovern DP; Weber CR; Hanson EM; Eckmann L; McCole DF
J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623320
[TBL] [Abstract][Full Text] [Related]
60. Mitigation effect of hesperidin on X-ray radiation-induced intestinal barrier dysfunction in Caco-2 cell monolayers.
Park HY; Yu JH
Food Chem Toxicol; 2024 Apr; 186():114549. PubMed ID: 38442786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
